Growth hormone treatment and aortic dimensions in turner syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 5, 2006, Pages 1785-1788

  Bondy, Carolyn A ^a   Van Phillip, L ^a   Bakalov, Vladimir K ^a   Ho, Vincent B ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADULT; AORTA; AORTA DISSECTION; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; PRIORITY JOURNAL; TURNER SYNDROME;

ADOLESCENT; AORTA; AORTA, THORACIC; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; GROWTH HORMONE; HUMANS; MAGNETIC RESONANCE IMAGING; MITRAL VALVE; RETROSPECTIVE STUDIES; TURNER SYNDROME;

EID: 33646386665     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2625     Document Type: Article

References (31)

1. Lippe B 1991 Turner syndrome. Endocrinol Metab Clin North Am 20:121-152
2. Nielsen J, Wohlert M 1991 Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 87:81-83
3. Delgado JA, Trahms CM, Sybert VP 1986 Measurement of body fat in Turner syndrome. Clin Genet 29:291-297
4. Rao E, Weiss B, Fukami M, Rump Andreas, Niesler B, Mertz A, Muroya K, Binder G, Kirsch S, Winkelmann M, Nordsiek G, Heinrich U, Breuning MH, Ranke MB, Rosenthal A, Ogata T, Rappold GA 1997 Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 16:54-63
5. McCauley E, Feuillan P, Kushner H, Ross JL 2001 Psychosocial development in adolescents with Turner syndrome. J Dev Behav Pediatr 22:360-365
6. Soriano-Guillen L, Coste J, Ecosse E, Leger J, Tauber M, Cabrol S, Nicolino M, Brauner R, Chaussain J-L, Carel J-C 2005 Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone. J Clin Endocrinol Metab 90:5197-5204
7. Pasquino AM, Pucarelli I, Segni M, Tarani L, Calcaterra V, Larizza D 2005 Adult height in sixty girls with Turner syndrome treated with growth hormone matched with an untreated group. J Endocrinol Invest 28:350-356
8. The Canadian Growth Hormone Advisory Committee 2005 Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian Randomized Controlled Trial. J Clin Endocrinol Metab 90:3360-3366
9. van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Stokvis-Brantsma WH, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL 2003 Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 88:1119-1125
10. Colao A, Vitale G, Pivonello R, Ciccarelli A, Di Somma C, Lombardi G 2004 The heart: an end-organ of GH action. Eur J Endocrinol 151:S93-S101
11. Maison P, Chanson P 2003 Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis. Circulation 108:2648-2652
12. Shulman DI, Root AW, Diamond FB, Bercu BB, Martinez R, Boucek Jr RJ 2003 Effects of one year of recombinant human growth hormone (GH) therapy on cardiac mass and function in children with classical GH deficiency. J Clin Endocrinol Metab 88:4095-4099
13. Cittadini A, Berggren A, Longobardi S, Ehrnborg C, Napoli R, Rosen T, Fazio S, Caidahl K, Bengtsson B-A, Sacca L 2002 Supraphysiological doses of GH induce rapid changes in cardiac morphology and function. J Clin Endocrinol Metab 87:1654-1659
14. Andersson IJ, Johansson ME, Wickman A, Bohlooly YM, Klintland N, Caidahl K, Gustafsson M, Boren J, Gan LM, Bergstrom G 2005 Endothelial dysfunction in growth hormone transgenic mice. Clin Sci 27:27
15. Lanes R, Soros A, Flores K, Gunczler P, Carrillo E, Bandel J 2005 Endothelial function, carotid artery intima-media thickness, epicardial adipose tissue, and left ventricular mass and function in growth hormone-deficient adolescents: apparent effects of growth hormone treatment on these parameters. J Clin Endocrinol Metab 90:3978-3982
16. Erikstrup C, Pedersen LM, Heickendorff L, Ledet T, Rasmussen LM 2001 Production of hyaluronan and chondroitin sulphate proteoglycans from human arterial smooth muscle - the effect of glucose, insulin, IGF-I or growth hormone. Eur J Endocrinol 145:193-198
17. Bruel A, Oxlund H 2002 Growth hormone influences the content and composition of collagen in the aorta from old rats. Mech Ageing Dev 123:627-635
18. Grothues F, Smith GC, Moon JCC, Bellenger NG, Collins P, Klein HU, Pennell DJ 2002 Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 90:29-34
19. Lin AE, Lippe B, Rosenfeld RG 1998 Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome. Pediatrics 102:e12
20. Gravholt CH, Naeraa RW, Brixen K, Kastrup KW, Mosekilde L, Jorgensen JOL, Christiansen JS 2002 Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study. Pediatrics 110:889-896
21. Radetti G, Crepaz R, Milanesi O, Paganini C, Cesaro A, Rigon F, Pitscheider W 2001 Cardiac performance in Turner's syndrome patients on growth hormone therapy. Horm Res 55:240-244
22. Sas TC, Cromme-Dijkhuis AH, de Muinck Keizer-Schrama SM, Stijnen T, van Teunenbroek A, Drop SL 1999 The effects of long-term growth hormone treatment on cardiac left ventricular dimensions and blood pressure in girls with Turner's syndrome. Dutch Working Group on Growth Hormone. J Pediatr 135:470-476
23. Cooley M, Bakalov V, Bondy CA 2003 Lipid profiles in women with 45, X vs 46, XX primary ovarian failure. JAMA 290:2127-2128
24. Bakalov VK, Cooley MM, Quon MJ, Luo ML, Yanovski JA, Nelson LM, Sullivan G, Bondy CA 2004 Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab 89:3516-3520
25. Gravholt CH, Juul S, Naeraa RW, Hansen J 2004 Epidemiological, endocrine and metabolic features in Turner syndrome Eur J Endocrinol 151:657-687
26. Yucel EK, Anderson CM, Edelman RR, Grist TM, Baum RA, Manning WJ, Culebras A, Pearce W 1999 Magnetic resonance angiography : update on applications for extracranial arteries. Circulation 100:2284-2301
27. Ostberg JE, Thomas EL, Hamilton G, Hosseinzadeh Attar MJ, Bell JD, Conway GS 2005 Excess visceral and hepatic adipose tissue in Turner syndrome determined by magnetic resonance imaging: oestrogen deficiency associated with hepatic adipose content. J Clin Endocrinol Metab 90:2631-2635
28. Ostberg JE, Brookes JAS, McCarthy C, Halcox J, Conway GS 2004 A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome. J Clin Endocrinol Metab 89:5966-5971
29. Sarkozy A, Conti E, Seripa D, Digilio MC, Grifone N, Tandoi C, Fazio VM, Di Ciommo V, Marino B, Pizzuti A, Dallapiccola B 2003 Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes. J Med Genet 40:704-708
30. Thuesen L, Jorgensen JO, Muller JR, Kristensen BO, Skakkebaek NE, Vahl N, Christiansen JS 1994 Short and long-term cardiovascular effects of growth hormone therapy in growth hormone-deficient adults. Clin Endocrinol (Oxf) 41:615-620
31. Cecconi M, Manfrin M, Moraca A, Zanoli R, Colonna PL, Bettuzzi MG, Moretti S, Gabrielli D, Perna GP 2005 Aortic dimensions in patients with bicuspid aortic valve without significant valve dysfunction. Am J Cardiol 95:292-294